Oncolyze
New York, US · Delaware corporation
Founders & leadership
BC
Barbara CarlinNamed on SEC filing
SJ
Steven J. EvansNamed on SEC filing
RM
Rosemary MazanetNamed on SEC filing
AZ
Alexander ZukiwskiNamed on SEC filing
AS
Aleksandar StojanovicNamed on SEC filing
JF
James FoghtNamed on SEC filing
LA
Larry AltstielNamed on SEC filing
JA
John AbelesNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$425K disclosed across 1 round · 2022
▶$425KraisedJul 2022 · 4 investors · BiotechnologyRule 506(c)
▶$425KraisedJul 2022 · 4 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Barbara CarlinExecutive Officer
- Steven J. EvansExecutive Officer, Director
- Rosemary MazanetDirector
- Alexander ZukiwskiDirector
- Aleksandar StojanovicExecutive Officer
- James FoghtDirector
- Larry AltstielExecutive Officer
- John AbelesDirector
- Offering amount
- $527.6K
- Amount sold
- $425K
- Sales commissions
- $51K
- Placement agents
- Ceros Financial Services, Inc.
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Oncolyze raised?
- Oncolyze has disclosed $425K raised across 1 round.
- Where is Oncolyze headquartered?
- Oncolyze is headquartered in New York, US.